Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot example

Nawaf Abu-Khalaf, Abdel Naser Zaid, Nidal Jaradat, Alaaldin M Alkilany, Samer R Abulateefeh, Rowa Al Ramahi, Mashhour Ghanem
  • Drug Design Development and Therapy, September 2019, Taylor & Francis
  • DOI: 10.2147/dddt.s214228

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/dddt.s214228

The following have contributed to this page: Abdel Naser Zaid and nidal jaradat